News News
CME CME
Clinical Guidance Clinical Guidance

Log In Log In
Log Out Log Out

News News
CME CME
Clinical Guidance Clinical Guidance

Specialties

Choose a specialty

All Specialties Allergy/Asthma Cardiac/Vascular Intervention Cardiology Dermatology Endocrinology Gastroenterology Hematology/Oncology Hepatology Infectious Disease Nephrology Neurology Ophthalmology Optometry Orthopedics Pediatrics Primary Care Psychiatry Pulmonology Rheumatology Women's Health & OB/GYN
Home
Headline News
Meeting News
Podcasts
Blogs & Columns
Resources

All Specialties
Allergy/Asthma
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
Women's Health & OB/GYN

Hematology/Oncology Subspecialties
Bone Marrow Transplantation
Breast Cancer
Cancer Prevention
Cell Therapy
Gastrointestinal Cancer
Genitourinary Cancer
Geriatric Oncology
Gynecologic Cancer
Head/Neck Cancer
Hematologic Malignancies
Hematology
Leukemia
Lung Cancer
Lymphoma
Melanoma/Skin Cancer
Myeloma
Myeloproliferative Neoplasms
Neuro-Oncology
Palliative Care
Pediatric Hematology
Pediatric Oncology
Practice Management
Prostate Cancer
Sarcoma
Survivorship

Blogs & Columns

Account Account

Log Out Log Out

Healio
News
Hematology/Oncology
Current Issues

HemOnc Today Current Issue

Related Resources

About Us
Advertising Information
Contact the Editor
Editorial Policy and Philosophy
Meet the Editorial Board
Mission Statement
Subscribe
Renew
Twitter

Year

Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

Rituximab, an effective first-line treatment for acute and relapsed TTP

Related Resources

About Us
Advertising Information
Contact the Editor
Editorial Policy and Philosophy
Meet the Editorial Board
Mission Statement
Subscribe
Renew
Twitter

Play on Healio

Follow Healio

Twitter
Facebook
Instagram
Threads
LinkedIn

About

About Healio About Healio
About the Wyanoke Group About the Wyanoke Group
Editorial Policy and Philosophy Editorial Policy and Philosophy
Sitemap Sitemap

Account Information

My Account Login
My Account My Account
Help Help
Email Subscriptions Email Subscriptions
Email Subscriptions Email Subscriptions Unknown
Newspaper and Journal Subscriptions Newspaper and Journal Subscriptions

Contact Us

Email Us Email Us
Contact Newsroom Contact Newsroom
Advertising Information Advertising Information
Permissions and Reprints Permissions and Reprints

Legal

Do Not Sell My Personal Information Do Not Sell My Personal Information
Terms and Conditions Terms and Conditions
Medical Disclaimer Medical Disclaimer
Privacy Policy Privacy Policy

Sign Up for Email

Get the latest news and education delivered to your inbox

Email address

Enter your email

Update email address

Specialty

Update email address

The email address associated with your Healio account is:

If you would like to edit or change the email address that your subscriptions and alerts are sent to, use the "Update email address" link.

Update email address

© Healio All Rights Reserved.

We’re sorry, but an unexpected error has occurred.

Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.

Would you like to receive email reminders to complete your saved activities from Healio CME?

Yes

No

Activity saved! You'll receive reminders to complete your saved activities from Healio CME.